Panama is not the right choice for every family
This treatment offers those whose condition has not improved with other treatments, a further option to control their symptoms, she said.
(10) Gut Health and Healing Research in model organismss indicates that BPC-157 may support gut health by: Strengthening the Gut Lining: Enhances the mucosal integrity, which is the protective layer of the stomach and intestines Reducing Inflammation: Helps calm gut irritation and inflammatory conditions Promoting Tissue Repair: Accelerates the healing of damaged tissue in the gut Protecting Blood Vessels: Supports healthy blood vessel function, improving circulation to injured areas These effects have been observed in several conditions: Gastric Ulcers: Accelerates healing, outperforms some ulcer medications, and promotes tissue regeneration (11) Inflammatory Bowel Disease (IBD): Enhances mucosal integrity, reduces inflammation, and supports epithelial repair (12) Gut Surgery: Improves healing of intestinal connections (anastomoses) and abnormal gut fistulas (13, 14) Overall Gut Health: Supports blood vessel formation, protects the gut lining, and may help with IBS symptoms (12) Damage Protection: Shields against alcohol, Nonsteroidal anti-inflammatory drugs (NSAIDs) are over-the-counter medications commonly used to reduce inflammation and pain NSAIDs, and toxins while aiding healing in the esophagus, liver, and pancreas (13) Neurological Protection and the Gut-Brain Axis Animal studies have demonstrated that BPC-157 has broad neuroprotective and therapeutic effects, including: Neuroprotection and Recovery: Supports nerve regeneration, protects against spinal cord injury, brain trauma, and neurotoxicity (14, 15) Neurotransmitter Regulation: Modulates dopamine, serotonin, and GABA, influencing seizures, tremors, addiction, and neurological disorders (16) Behavioral and Cognitive Support: Improves motor function, learning, mood disorders, and neurological decline (16) By promoting both gut healing and neuroprotection, BPC-157 is a promising therapy for conditions linked to the gut-brain axis, supporting systemic healing and recovery
Eighteen patients (90%) were treated using retrograde approach
Discontinuing prematurely may prevent any meaningful assessment of efficacy
